Podcasts and Further Resources
Our series ‘Prof Talks’ dives into the science behind the Attomarker COVID Antibody Spectrum Test as well as covering topics such as ‘Hyper-immunity’ and ‘Children and Long COVID’.
We also run additional episodes with clinicians such as Dr Ben Sinclair covering the latest research in Long COVID recovery: turning the science into medicine.
Links to podcasts are available on this website and on our
YouTube Channel.
Professor Shaw and Attomarker also feature in other podcasts, programmes and articles, including:
Listen to our latest webinar with Prof Andrew Shaw and Dr Deb Giorgi-Guarnieri, based in the US. Dr Deb G-G has special interest in treating psychiatric complications of Long COVID and Vaccine Injury.
View our latest Blogs
Science Briefing: COVID-19 Antibody Immunity Testing – Interpreting the Results
Attomarker has developed a COVID-19 Antibody Immunity test which is fully CE marked and is fully quantitative referenced to the NIST standard human antibody.The test is a fully quantitative immunoassay calibrated against the conserved S2 regions of the spike protein,...
Science Briefing: COVID-19 Antibody Immunity Testing vs. T Cell Immunity
What is Immunity? Immunity is a complex process with both innate and adaptive immunity. The adaptive arm of the immune system comprises both antibody responses and T cell responses. Most recently, the role of T cells and antibodies has become an important point of...
Science Briefing: Quantitative Antibody Testing against the NIST Standard
The Attomarker COVID-19 Antibody Immunity Test is a fully quantitative immunoassay calibrated against the conserved S2 regions of the spike protein, omicron spike protein, nucleocapsid and receptor binding domain proteins with recombinant antibodies calibrated against...
What is Long COVID?
What is Long Covid? Long Covid, also known as long-haul covid or post-acute COVID syndrome (PACS), is being increasingly discussed in the media as cases persist in the United Kingdom. Both the NHS and the CDC identify it as COVID-19 symptoms that continue for longer...
Back to School: Are our teachers safe from COVID?
After a long hot summer COVID has not been at the forefront of people's minds but it certainly hasn't gone away. As we know from the latest vaccine rollout plans, new Omicron variants have been circulating extensively in the population. It is widely accepted that...
What is Smart Boosting?
Antibody levels and antibody immunity vary widely in the population, and we are about to boost people based on age alone. Before COVID, antibody levels were found to correlate with protection in 18 other vaccines [1] and antibody levels following the third boost are...
UK leads the vaccine race again – but are we making the right choices?
The UK Health Security Agency (UKHSA) announced on August 22nd the widely trailed information that a 4th vaccination shot for COVID-19 would be rolled out to all over 50s from early September. The great majority of these shots will be the Moderna bivalent Omicron...
Case Study: Integra Healthcare in the Cayman Islands
Attomarker has partnered with Integra Healthcare in the Cayman Islands, where only 31% of the population has received a boosterdose. The medical team introduced the test to the community with a VIP launch and an informative...
Attomarker Technology Overview
Attomarker technology is a label-free particle plasmon resonance multiplexed array that can measure the concentration quantitatively for up to 20 species in 10 µL blood sample in 7 minutes. The original idea came from a...
